HRP20050534A2 - Prevention and treatment of alzheimer's disease - Google Patents
Prevention and treatment of alzheimer's diseaseInfo
- Publication number
- HRP20050534A2 HRP20050534A2 HR20050534A HRP20050534A HRP20050534A2 HR P20050534 A2 HRP20050534 A2 HR P20050534A2 HR 20050534 A HR20050534 A HR 20050534A HR P20050534 A HRP20050534 A HR P20050534A HR P20050534 A2 HRP20050534 A2 HR P20050534A2
- Authority
- HR
- Croatia
- Prior art keywords
- inhibitor
- alzheimer
- disease
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
Prikazani izum se odnosi na primjenu inhibitora intestinalnog apsorpcije bilijarnih kiselina u prevenciji i liječenju Alzheimerove bolesti, po izboruu kombinaciji sa inhibitorom HMG-CoA reduktaze, inhibitorom apsorpcije kolesterola, inhibitorom sinteze kolesterola ili inhibitorom APP sekretaze.The present invention relates to the use of an inhibitor of intestinal biliary acid absorption in the prevention and treatment of Alzheimer's disease, optionally in combination with an HMG-CoA reductase inhibitor, a cholesterol absorption inhibitor, a cholesterol synthesis inhibitor or an APP secretase inhibitor.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0215722A FR2848452B1 (en) | 2002-12-12 | 2002-12-12 | APPLICATION OF INTESTINAL BILIARY ACID RECAPTURE INHIBITORS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE |
PCT/FR2003/003654 WO2004062652A1 (en) | 2002-12-12 | 2003-12-10 | Prevention and treatment of alzheimer's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20050534A2 true HRP20050534A2 (en) | 2006-11-30 |
Family
ID=32338722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20050534A HRP20050534A2 (en) | 2002-12-12 | 2005-06-10 | Prevention and treatment of alzheimer's disease |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1572174A1 (en) |
JP (1) | JP2006514063A (en) |
KR (1) | KR20050084250A (en) |
CN (1) | CN1726016A (en) |
AR (1) | AR042354A1 (en) |
AU (1) | AU2003296802A1 (en) |
BR (1) | BR0317280A (en) |
CA (1) | CA2507945A1 (en) |
CO (1) | CO5700712A2 (en) |
FR (1) | FR2848452B1 (en) |
HR (1) | HRP20050534A2 (en) |
MA (1) | MA27500A1 (en) |
MX (1) | MXPA05005556A (en) |
NO (1) | NO20053341L (en) |
NZ (1) | NZ540496A (en) |
PE (1) | PE20040770A1 (en) |
PL (1) | PL377110A1 (en) |
RS (1) | RS20050420A (en) |
RU (1) | RU2005121909A (en) |
TW (1) | TW200503707A (en) |
WO (1) | WO2004062652A1 (en) |
ZA (1) | ZA200504656B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
NZ546887A (en) | 2003-11-03 | 2009-04-30 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
AU2005210004B2 (en) | 2004-02-05 | 2010-10-28 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
EP1812007B1 (en) | 2004-11-02 | 2011-09-07 | Northwestern University | Pyridazine compounds and methods |
EP2015750A2 (en) | 2006-04-28 | 2009-01-21 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
UA96633C2 (en) * | 2007-05-22 | 2011-11-25 | Оцука Фармасьютікал Ко., Лтд. | Medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease |
EA201891154A1 (en) | 2011-10-28 | 2019-02-28 | ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи | INHIBITORS OF BILIC ACID RECYCLING IN THE TREATMENT OF CHOLESTATIC DISEASES OF THE LIVER IN CHILDREN |
US20130108573A1 (en) * | 2011-10-28 | 2013-05-02 | Lumena Pharmaceuticals, Inc. | Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2040996A1 (en) * | 1990-05-02 | 1991-11-03 | Robert L. Albright | Composition and method for controlling cholesterol |
AU668682B2 (en) * | 1991-02-22 | 1996-05-16 | Howard K. Shapiro | Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
US6491903B1 (en) * | 1996-06-27 | 2002-12-10 | Washington University | Particles comprising amphiphilic copolymers |
US5985936A (en) * | 1997-12-18 | 1999-11-16 | Forbes Medi-Tech, Inc. | Method of preventing and delaying onset of Alzheimer's disease and composition therefor |
DE69833971T2 (en) * | 1998-01-28 | 2006-11-02 | Warner-Lambert Co. Llc | METHOD FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
US6080778A (en) * | 1998-03-23 | 2000-06-27 | Children's Medical Center Corporation | Methods for decreasing beta amyloid protein |
DE19825804C2 (en) * | 1998-06-10 | 2000-08-24 | Aventis Pharma Gmbh | 1,4-Benzothiepin-1,1-dioxide derivatives, processes for their preparation and medicaments containing these compounds |
US6221897B1 (en) * | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
DE19845405C2 (en) * | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Aryl-substituted propanolamine derivatives and their use |
US20010028895A1 (en) * | 2000-02-04 | 2001-10-11 | Bisgaier Charles L. | Methods of treating alzheimer's disease |
US20020028826A1 (en) * | 2000-06-15 | 2002-03-07 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
SE0104334D0 (en) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
TWI329111B (en) * | 2002-05-24 | 2010-08-21 | X Ceptor Therapeutics Inc | Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
-
2002
- 2002-12-12 FR FR0215722A patent/FR2848452B1/en not_active Expired - Fee Related
-
2003
- 2003-12-10 RS YUP-2005/0420A patent/RS20050420A/en unknown
- 2003-12-10 KR KR1020057010595A patent/KR20050084250A/en not_active Application Discontinuation
- 2003-12-10 RU RU2005121909/15A patent/RU2005121909A/en not_active Application Discontinuation
- 2003-12-10 AR ARP030104540A patent/AR042354A1/en not_active Application Discontinuation
- 2003-12-10 CN CNA2003801059727A patent/CN1726016A/en active Pending
- 2003-12-10 AU AU2003296802A patent/AU2003296802A1/en not_active Abandoned
- 2003-12-10 PL PL377110A patent/PL377110A1/en not_active Application Discontinuation
- 2003-12-10 JP JP2004566119A patent/JP2006514063A/en not_active Abandoned
- 2003-12-10 PE PE2003001247A patent/PE20040770A1/en not_active Application Discontinuation
- 2003-12-10 MX MXPA05005556A patent/MXPA05005556A/en not_active Application Discontinuation
- 2003-12-10 BR BR0317280-5A patent/BR0317280A/en not_active IP Right Cessation
- 2003-12-10 EP EP03815109A patent/EP1572174A1/en not_active Withdrawn
- 2003-12-10 WO PCT/FR2003/003654 patent/WO2004062652A1/en active Application Filing
- 2003-12-10 CA CA002507945A patent/CA2507945A1/en not_active Abandoned
- 2003-12-10 NZ NZ540496A patent/NZ540496A/en unknown
- 2003-12-11 TW TW092134949A patent/TW200503707A/en unknown
-
2005
- 2005-06-07 ZA ZA200504656A patent/ZA200504656B/en unknown
- 2005-06-09 CO CO05056010A patent/CO5700712A2/en not_active Application Discontinuation
- 2005-06-10 MA MA28329A patent/MA27500A1/en unknown
- 2005-06-10 HR HR20050534A patent/HRP20050534A2/en not_active Application Discontinuation
- 2005-07-08 NO NO20053341A patent/NO20053341L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA200504656B (en) | 2006-08-30 |
JP2006514063A (en) | 2006-04-27 |
CN1726016A (en) | 2006-01-25 |
EP1572174A1 (en) | 2005-09-14 |
WO2004062652A1 (en) | 2004-07-29 |
TW200503707A (en) | 2005-02-01 |
NO20053341L (en) | 2005-09-07 |
BR0317280A (en) | 2005-11-08 |
NZ540496A (en) | 2008-04-30 |
KR20050084250A (en) | 2005-08-26 |
RS20050420A (en) | 2007-04-10 |
RU2005121909A (en) | 2006-01-20 |
MXPA05005556A (en) | 2005-07-26 |
MA27500A1 (en) | 2005-08-01 |
CO5700712A2 (en) | 2006-11-30 |
AR042354A1 (en) | 2005-06-15 |
FR2848452A1 (en) | 2004-06-18 |
FR2848452B1 (en) | 2007-04-06 |
NO20053341D0 (en) | 2005-07-08 |
PE20040770A1 (en) | 2004-12-10 |
CA2507945A1 (en) | 2004-07-29 |
PL377110A1 (en) | 2006-01-23 |
AU2003296802A1 (en) | 2004-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20050534A2 (en) | Prevention and treatment of alzheimer's disease | |
DE60112055D1 (en) | INHIBITORS OF GAMMA SECRETASE | |
TNSN01125A1 (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING A CETP AND ATORVASTATIN INHIBITOR | |
DE60312017D1 (en) | SULPHONE DERIVATIVES FOR INHIBITING GAMMA SECRETASE | |
ECSP045429A (en) | COMBINATION OF ORGANIC COMPOUNDS | |
UY27972A1 (en) | HIDANTOINE DERIVATIVES | |
ATE443043T1 (en) | PHENYLCARBOXAMIDE AS A BETA-SECRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER'S | |
ATE464287T1 (en) | CYCLOHEXYL SULPHONES AS GAMMA SECRETASE INHIBITORS | |
DE60124684D1 (en) | SULPHONAMIDO-SUBSTITUTED BROKEN BICYCLOALKYL DERIVATIVES | |
PA8577901A1 (en) | PHARMACEUTICAL FORMULATION | |
ATE416761T1 (en) | PREVENTION AND TREATMENT OF INFLAMMATORY AND/OR IMMUNE-MEDIATED BONE LOSS | |
DE60237725D1 (en) | DEVICE OF DEXRAZOXANE IN THE PREVENTION AND TREATMENT OF ALZHEIMER DISEASE | |
EE200100405A (en) | Use of 3-hydroxy-3-methylglutaryl coenzyme as a reductase inhibitor in the preparation of a medicament for the treatment of diabetic neuropathy | |
PT1115701E (en) | ARILSULFONANILIDA UREES | |
ATE482936T1 (en) | 2-AMINO-QUINAZOLINE DERIVATIVES USEFUL AS B-SECRETASE (BACE) INHIBITORS | |
NO20074941L (en) | Use of diosmetine compounds in the treatment and prevention of thrombotic pathologies | |
MXPA04000793A (en) | Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma. | |
PA8583601A1 (en) | PIRROLIDONE DERIVATIVES AS MAOB INHIBITORS | |
NO20056218L (en) | Substituted pyrrole derivatives and their use as HMF-CoA reductase inhibitors | |
BR0318278A (en) | aminocyclohexyl ether compounds and uses thereof | |
HUP0301991A2 (en) | Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis | |
BRPI0518300A2 (en) | 7- (2h-pyrazol-3-yl) -3,5-dihydroxyheptanoic acid derivatives as hmg co-reductase inhibitors for the treatment of lipidemia | |
AU2003231252A1 (en) | Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease | |
MXPA05009986A (en) | Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders. | |
WO2003106450A8 (en) | Phenylaminopyrimidines and their use as rho-kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20071207 Year of fee payment: 5 |
|
OBST | Application withdrawn |